Andrew Booth, Chief Financial Officer of AbCellera Biologics Inc., filed a Form 4 on November 16, 2026, disclosing transactions in common shares dated November 13, 2026, including a stock option exercise and a charitable donation of shares.

Key Highlights

  • Option exercise: Booth exercised a share option (transaction code M) for 50,000 common shares at a price of $0.3216 per share on November 13, 2026.
  • Charitable donation: Booth disposed of 50,000 common shares (transaction code G) at $0 on November 13, 2026, which the filing describes as a charitable donation.
  • Direct holdings after transactions: Booth directly beneficially owned 491,400 common shares following the reported transactions.
  • Indirect holdings: An additional 130,959 common shares are held indirectly by Booth's spouse.
  • Remaining derivative securities: Booth held 8,451,849 share options (rights to buy) directly following the reported transactions, with an exercise price of $0.3216 and an expiration date of August 22, 2029.
  • Filing entity: AbCellera Biologics Inc. is listed on NASDAQ:ABCL.

Andrew Booth's November 13 Option Exercise and Charitable Share Donation at AbCellera

According to the Form 4 filed with the SEC, Andrew Booth, Chief Financial Officer of AbCellera Biologics Inc. (NASDAQ:ABCL), reported two transactions in common shares on November 13, 2026. First, Booth exercised a share option covering 50,000 common shares at an exercise price of $0.3216 per share, reflected as an acquisition (transaction code M) in Table I. The option exercised is described in Table II as a share option (right to buy) with an expiration date of August 22, 2029, vesting annually in substantially equal installments over a four-year period, with the first tranche having vested on August 22, 2020, subject to the reporting person's continuous service to the issuer.

Following the exercise, the filing reports that Booth donated the same 50,000 common shares to charity (transaction code G) at a price of $0, as explained in the footnotes: "This transaction represents a charitable donation of 50,000 common shares the reporting person donated on November 13, 2026." After these two transactions, Booth's direct beneficial ownership in common shares stood at 491,400 shares. An additional 130,959 common shares are reported as indirectly held by his spouse.

The Form 4 was signed by Tryn Stimart as attorney-in-fact on November 13, 2026, and filed on November 16, 2026. The filing was made by one reporting person and is not marked as an amendment. Following the transactions, Booth retained direct beneficial ownership of 8,451,849 share options according to the derivative securities table.

What Was Disclosed

AbCellera CFO Andrew Booth disclosed a share option exercise of 50,000 common shares at $0.3216 and an immediate charitable donation of those same 50,000 shares at $0, both on November 13, 2026, leaving him with 491,400 directly held common shares and 8,451,849 share options.